277 related articles for article (PubMed ID: 22496090)
21. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A
Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
[TBL] [Abstract][Full Text] [Related]
23. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
24. [Experience in the treatment with recombinant thrombomodulin on disseminated intravascular coagulation with severe urinary tract infection].
Fumino M; Kurimoto K; Kinoshita N; Kato H; Arima K; Sugimura Y
Hinyokika Kiyo; 2012 Feb; 58(2):71-4. PubMed ID: 22450831
[TBL] [Abstract][Full Text] [Related]
25. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kuroda T; Sakata Y
Thromb Res; 2013 May; 131(5):436-43. PubMed ID: 23566534
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
[TBL] [Abstract][Full Text] [Related]
27. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
[TBL] [Abstract][Full Text] [Related]
28. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
[TBL] [Abstract][Full Text] [Related]
29. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Efficacy of Recombinant Human Thrombomodulin for Surgical Patients with Disseminated Intravascular Coagulation Associated with Oncologic Emergency].
Ikuta L; Nakajima T; Fujikawa M; Nomura K; Matsuki G; Ichise N; Kasai M; Okamoto R; Ikuta S; Nakamoto Y; Aihara T; Yanagi H; Yamanaka N
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1408-1410. PubMed ID: 36733084
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
[TBL] [Abstract][Full Text] [Related]
32. [A case of miliary tuberculosis complicated by disseminated intravascular coagulation and acute respiratory distress syndrome successfully treated with recombinant human soluble thrombomodulin].
Shiraishi S; Futami S; Kurahara Y; Tsuyuguchi K; Hayashi S; Suzuki K
Kekkaku; 2012 Dec; 87(12):771-6. PubMed ID: 23350518
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients.
Eguchi T; Tsuji Y; Yamashita H; Fukuchi T; Kanamori A; Matsumoto K; Hasegawa T; Koizumi A; Kitada R; Tsujimae M; Iwatsubo T; Koyama S; Ubukata S; Fujita M; Okada A
Pancreatology; 2015; 15(5):485-490. PubMed ID: 26320826
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
[TBL] [Abstract][Full Text] [Related]
35. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.
Ikezoe T; Takeuchi A; Chi S; Takaoka M; Anabuki K; Kim T; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Eur J Haematol; 2013 Nov; 91(5):442-7. PubMed ID: 23952647
[TBL] [Abstract][Full Text] [Related]
37. [Case report of disseminated carcinomatosis of the bone marrow originating from gastric cancer with cancer-related disseminated intravascular coagulation successfully treated with recombinant human soluble thrombomodulin].
Kawamoto H; Uchida Y; Ueda S; Yanagita S; Terajima H
Gan To Kagaku Ryoho; 2015 Mar; 42(3):363-5. PubMed ID: 25812509
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.
Tamura K; Saito H; Asakura H; Okamoto K; Tagawa J; Hayakawa T; Aoki N
Int J Clin Oncol; 2015 Aug; 20(4):821-8. PubMed ID: 25385713
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
[TBL] [Abstract][Full Text] [Related]
40. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]